Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9980 | 1038 | 42.0 | 89% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1432 | 7402 | THROMBOPOIETIN//ONCOSTATIN M//LEUKEMIA INHIBITORY FACTOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ONCOSTATIN M | Author keyword | 109 | 52% | 15% | 151 |
2 | LEUKEMIA INHIBITORY FACTOR | Author keyword | 43 | 27% | 13% | 138 |
3 | LEUKAEMIA INHIBITORY FACTOR | Author keyword | 14 | 36% | 3% | 32 |
4 | ONCOSTATIN M RECEPTOR | Author keyword | 8 | 75% | 1% | 6 |
5 | GP130 | Author keyword | 6 | 12% | 5% | 47 |
6 | LEUKEMIA INHIBITORY FACTOR LIF | Author keyword | 6 | 28% | 2% | 17 |
7 | D FACTOR | Author keyword | 5 | 63% | 0% | 5 |
8 | LEUKEMIA INHIBITORY FACTOR RECEPTOR | Author keyword | 4 | 38% | 1% | 9 |
9 | OSM | Author keyword | 4 | 25% | 1% | 13 |
10 | MCLM 395 | Address | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ONCOSTATIN M | 109 | 52% | 15% | 151 | Search ONCOSTATIN+M | Search ONCOSTATIN+M |
2 | LEUKEMIA INHIBITORY FACTOR | 43 | 27% | 13% | 138 | Search LEUKEMIA+INHIBITORY+FACTOR | Search LEUKEMIA+INHIBITORY+FACTOR |
3 | LEUKAEMIA INHIBITORY FACTOR | 14 | 36% | 3% | 32 | Search LEUKAEMIA+INHIBITORY+FACTOR | Search LEUKAEMIA+INHIBITORY+FACTOR |
4 | ONCOSTATIN M RECEPTOR | 8 | 75% | 1% | 6 | Search ONCOSTATIN+M+RECEPTOR | Search ONCOSTATIN+M+RECEPTOR |
5 | GP130 | 6 | 12% | 5% | 47 | Search GP130 | Search GP130 |
6 | LEUKEMIA INHIBITORY FACTOR LIF | 6 | 28% | 2% | 17 | Search LEUKEMIA+INHIBITORY+FACTOR+LIF | Search LEUKEMIA+INHIBITORY+FACTOR+LIF |
7 | D FACTOR | 5 | 63% | 0% | 5 | Search D+FACTOR | Search D+FACTOR |
8 | LEUKEMIA INHIBITORY FACTOR RECEPTOR | 4 | 38% | 1% | 9 | Search LEUKEMIA+INHIBITORY+FACTOR+RECEPTOR | Search LEUKEMIA+INHIBITORY+FACTOR+RECEPTOR |
9 | OSM | 4 | 25% | 1% | 13 | Search OSM | Search OSM |
10 | LIFR BETA | 2 | 50% | 0% | 3 | Search LIFR+BETA | Search LIFR+BETA |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUMAN INTERLEUKIN | 77 | 68% | 7% | 68 |
2 | DA CELLS | 55 | 69% | 5% | 47 |
3 | M OSM | 53 | 95% | 2% | 18 |
4 | FACTOR LIF | 44 | 35% | 10% | 104 |
5 | GROWTH REGULATOR | 27 | 43% | 5% | 48 |
6 | IL 6 SIGNAL TRANSDUCER | 26 | 28% | 8% | 79 |
7 | LIF RECEPTOR | 25 | 52% | 3% | 34 |
8 | FACTOR INDUCING DIFFERENTIATION | 17 | 72% | 1% | 13 |
9 | FACTOR HUMAN INTERLEUKIN | 15 | 88% | 1% | 7 |
10 | ONCOSTATIN M | 14 | 12% | 11% | 110 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The neuropoietic cytokine family in development, plasticity, disease and injury | 2007 | 153 | 173 | 23% |
Leukemia-inhibitory factor - Neuroimmune modulator of endocrine function | 2000 | 140 | 423 | 37% |
gp130 cytokine family and bone cells | 2000 | 104 | 189 | 36% |
The dual role of IL-6-type cytokines on bone remodeling and bone tumors | 2009 | 43 | 71 | 24% |
Leukemia inhibitory factor, interleukin 6, and other cytokines using the GP130 transducing receptor: Roles in inflammation and injury | 1999 | 126 | 157 | 32% |
The unsolved enigmas of leukemia inhibitory factor | 2003 | 119 | 86 | 51% |
Oncostatin M: Signal transduction and biological activity | 1999 | 62 | 90 | 51% |
The oncostatin M signalling pathway: reversing the neoplastic phenotype? | 1999 | 50 | 48 | 52% |
THE LEUKEMIA INHIBITORY FACTOR AND ITS RECEPTOR | 1993 | 112 | 121 | 52% |
GP130 cytokines and bone remodelling in health and disease | 2010 | 37 | 117 | 24% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MCLM 395 | 3 | 100% | 0.3% | 3 |
2 | UNIT CELL GENE THER Y | 3 | 60% | 0.3% | 3 |
3 | INSERM U463 | 2 | 19% | 0.8% | 8 |
4 | INSERM E 9928 | 1 | 100% | 0.2% | 2 |
5 | UMR 5540 | 1 | 14% | 0.9% | 9 |
6 | CELL FATE MODULAT UNIT | 1 | 40% | 0.2% | 2 |
7 | RECH INTERDISCIPLINAIRE TISSUS CALCIFIES BI | 1 | 40% | 0.2% | 2 |
8 | PHYSIOPATHOL ORPT OSSEUSE | 1 | 21% | 0.4% | 4 |
9 | HEMATOL EXPT | 1 | 11% | 0.6% | 6 |
10 | ANAT ANAT PATHOL | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000269000 | CILIARY NEUROTROPHIC FACTOR//CNTF//CNTFR ALPHA |
2 | 0.0000178536 | INTERLEUKIN 11//INTERLEUKIN 11 RECEPTOR//IL 11 |
3 | 0.0000156867 | CARDIOTROPHIN 1//CARDIOTROPHIN//ERK 1 AND 2 |
4 | 0.0000141471 | IL 6 RECEPTOR//INTERLEUKIN 6 RECEPTOR//GP130 |
5 | 0.0000094527 | HYPOTHALAMIC FACTORS//IL 6 MESSENGER RNA//INTRAUTERINE SURVIVAL |
6 | 0.0000067345 | IMPLANTATION//ENDOMETRIAL RECEPTIVITY//ENDOMETRIUM |
7 | 0.0000066342 | LONGEV SCI//HOSP GERIATR MED//TORAT MED |
8 | 0.0000056268 | STAT3//STAT5//STAT |
9 | 0.0000050954 | SOCS//SOCS1//SOCS3 |
10 | 0.0000047346 | GM CSF RECEPTOR//BLAST COLONIES//COMMON BETA SUBUNIT |